Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis
- PMID: 17288544
- DOI: 10.1111/j.1432-0436.2006.00135.x
Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis
Abstract
Mice have been used extensively for studying normal prostate development and for generation of transgenic or knock-out prostate cancer animal models. To understand systematically and thoroughly the androgen responsive program in the mouse prostate, we carried out microarray analysis to profile gene expression changes during prostate involution and re-growth triggered by castration and subsequent hormone replacement. Genes with significant changes in these two processes were identified and gene ontology analyses revealed that they were mainly involved in response mechanisms, cell adhesion, metabolism, protein metabolism, and cell-cycle progression. The changes observed during prostate involution were largely reversed during re-growth. Sixty-four genes, including Nkx3.1 and probasin, and 65 other genes, including insulin-like growth factor binding protein 3 and H-cadherin (H-Cad), were further identified respectively as androgen-responsive genes and genes inversely correlated with androgen, based on their down- or up-regulation following castration and up- or down-regulation following androgen replacement. Potential androgen-responsive elements were found in the 5' upstream promoter region of 47 of those 65 genes, suggesting a potential suppression mechanism by androgen receptor. Of these, the role of H-Cad in tumorigenesis was further evaluated. Reduction of H-Cad transcript level was found in the majority of human prostate cancer cell lines and prostatic adenocarcinoma samples examined. Furthermore, induced H-Cad expression in DU145 cells, and knock-down of H-Cad expression in BPH1 cells inhibited and facilitated tumorigenicity, respectively. Taken together, our study provides a molecular understanding of the mouse prostate involution and re-growth processes and identifies a set of genes that are inversely correlated with androgen and may be potentially suppressive for tumorigenesis.
Similar articles
-
Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.Cancer Res. 2000 Jun 1;60(11):3058-64. Cancer Res. 2000. PMID: 10850457
-
Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.Cancer Res. 2000 Nov 1;60(21):6134-41. Cancer Res. 2000. PMID: 11085537
-
The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.Cancer Res. 1999 May 1;59(9):2203-9. Cancer Res. 1999. PMID: 10232609
-
Molecular regulation of androgen action in prostate cancer.J Cell Biochem. 2006 Oct 1;99(2):333-44. doi: 10.1002/jcb.20794. J Cell Biochem. 2006. PMID: 16518832 Review.
-
Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.Ann N Y Acad Sci. 2005 Nov;1059:33-40. doi: 10.1196/annals.1339.018. Ann N Y Acad Sci. 2005. PMID: 16382041 Review.
Cited by
-
TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.PLoS One. 2011 Jan 18;6(1):e16205. doi: 10.1371/journal.pone.0016205. PLoS One. 2011. PMID: 21267413 Free PMC article.
-
Cellular cartography reveals mouse prostate organization and determinants of castration resistance.bioRxiv [Preprint]. 2024 Dec 27:2024.12.27.630532. doi: 10.1101/2024.12.27.630532. bioRxiv. 2024. PMID: 39763898 Free PMC article. Preprint.
-
CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor.Oncogene. 2014 Jan 23;33(4):504-13. doi: 10.1038/onc.2012.602. Epub 2013 Jan 14. Oncogene. 2014. PMID: 23318417 Free PMC article.
-
Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells.PLoS One. 2012;7(8):e42564. doi: 10.1371/journal.pone.0042564. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22880034 Free PMC article.
-
RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development.Elife. 2020 Oct 7;9:e60225. doi: 10.7554/eLife.60225. Elife. 2020. PMID: 33025905 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous